FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         	UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  	OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5	
                      	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	                      	

1. Name and Address of Reporting Person *

DOYLE WILLIAM F	2. Issuer Name and Ticker or Trading Symbol

Novocure Ltd [ NVCR ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      __ X __ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
Executive Chairman	
(Last)          (First)          (Middle)

C/O NOVOCURE INC.,, 20 VALLEY STREAM PKWY SUITE 300	3. Date of Earliest Transaction (MM/DD/YYYY)

1/3/2017		
(Street)

MALVERN, PA 19355
(City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)

 	6. Individual or Joint/Group Filing (Check Applicable Line)

___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person	

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned	
1.Title of Security
(Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code
(Instr. 8)	4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)	5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)	
			Code	V	Amount	(A) or (D)	Price				
Ordinary Shares  	1/3/2017  	 	J (1)	  	2242664  	D	  (1)	0  	I  	WFD Ventures Fund A, LLC   (2)	
Ordinary Shares  	 	 	 	  	 	 	 	19136038  	I  	WFD Ventures Fund II, L.P.   (3)	
Ordinary Shares  	 	 	 	  	 	 	 	84699  	D  	 	

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)	
1. Title of Derivate Security
(Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code
(Instr. 8)	5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)	6. Date Exercisable and Expiration Date	7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)	8. Price of Derivative Security
(Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)	
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares					

Explanation of Responses:	
(  1) 	On January 3, 2017, WFD Ventures Fund A, LLC distributed to its sole economic member all of the Issuer shares that it held in connection with its liquidation. Neither Mr. Doyle nor WFD Ventures Fund II, L.P. had any pecuniary interest in the distributed shares.	
(  2) 	Mr. Doyle is a managing director of WFD Ventures LLC, which is the managing member of WFD Ventures Fund A, LLC. Mr. Doyle disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest.	
(  3) 	Mr. Doyle is a managing director of WFD Ventures LLC, the sole member of WFD-GP II, LLC, which is the general partner of WFD Ventures Fund II, L.P. Mr. Doyle disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest.	

Remarks:
This Form 4 is filed for William F. Doyle and WFD Ventures Fund II, L.P.	

Reporting Owners	
Reporting Owner Name / Address	Relationships	
	Director	10% Owner	Officer	Other	
DOYLE WILLIAM F
C/O NOVOCURE INC.,
20 VALLEY STREAM PKWY SUITE 300
MALVERN, PA 19355	X	X	Executive Chairman		
WFD Ventures Fund II, L.P.
C/O NOVOCURE INC.,
20 VALLEY STREAM PKWY SUITE 300
MALVERN, PA 19355		X			

Signatures		
By: /s/ William F. Doyle		1/4/2017	
** Signature of Reporting Person		Date
	
WFD Ventures Fund II, L.P., By: WFD-GP II, LLC, its general partner, By: WFD Ventures LLC, sole member of WFD-GP II LLC, By: /s/ William F. Doyle, Title: Managing Director		1/4/2017	
** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.	
*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).	
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).	
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.	
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.